H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Onconova Therapeutics (ONTX – Research Report) yesterday and set a
Tag: Joseph Pantginis
H.C. Wainwright Believes Cytokinetics Inc (NASDAQ: CYTK) Still Has Room to Grow
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Cytokinetics Inc (CYTK – Research
H.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to Recover
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Caladrius Biosciences (CLBS – Research Report) today and set a
H.C. Wainwright Reiterates a Buy Rating on Avid Bioservices Inc (CDMO)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Avid Bioservices Inc (CDMO – Research Report) today and set
H.C. Wainwright Reiterates Their Buy Rating on Aptose Biosciences (APTO)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Aptose Biosciences (APTO – Research Report) today and set a
H.C. Wainwright Reiterates a Buy Rating on Dova Pharmaceuticals Inc (DOVA)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Dova Pharmaceuticals Inc (DOVA –
H.C. Wainwright Reiterates a Buy Rating on Xoma Corp (XOMA)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Xoma Corp (XOMA – Research